Research in Social and Administrative Pharmacy
Volume 6, Issue 3 , Pages 221-231 , September 2010

Consumers' views of pharmacogenetics—A qualitative study

  • Catherine A. Haddy, B.Pharm. (Hons.)

      Affiliations

    • School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Frome Road, Adelaide 5000, South Australia
  • ,
  • Helena M. Ward, B.Sc., Ph.D.

      Affiliations

    • School of Medicine, Flinders University, Adelaide, South Australia
  • ,
  • Manya T. Angley, B.Pharm., Ph.D.

      Affiliations

    • School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Frome Road, Adelaide 5000, South Australia
  • ,
  • Ross A. McKinnon, B.Pharm., Ph.D.

      Affiliations

    • School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Frome Road, Adelaide 5000, South Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61-8-83022372; fax: +61-8-83011087.

References 

  1. Clemerson JP, Payne K, Bissell P, Anderson C. Pharmacogenetics, the next challenge for pharmacy?. Pharm World Sci. 2006;28(3):126–130
  2. Lindpaintner K. Pharmacogenetics and the future of medical practice. Br J Clin Pharmacol. 2002;54(2):221–230
  3. Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature. 2004;429(6990):464–468
  4. Roses AD. Pharmacogenetics and the practice of medicine. Nature. 2000;405(6788):857–865
  5. Sadee W. Pharmacogenomics: the implementation phase. AAPS PharmSci. 2002;4(2):E5
  6. Gardiner SJ, Begg EJ. Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?. Pharmacogenet Genomics. 2005;15(5):365–369
  7. Corkindale D, Ward HM, McKinnon RA. Low adoption of pharmacogenetic testing: an exploration and explanation of the reasons in Australia. Personalized Med. 2007;4(2):191–199
  8. Martin PA, Lewis G, Smart A, Webster A. False Positive? The Commercial & Clinical Development of Pharmacogenetics. UK: University of Nottingham/University of York; 2006;
  9. Rogausch A, Prause D, Schallenberg A, Brockmoller J, Himmel W. Patients' and physicians' perspectives on pharmacogenetic testing. Pharmacogenomics. 2006;7(1):49–59
  10. Almarsdóttir AB, Björnsdóttir I, Traulsen JM. A lay prescription for tailor-made drugs–focus group reflections on pharmacogenomics. Health Policy. 2005;71(2):233–241
  11. Melzer D, Ravin A, Detmer D, Ling T, Zimmern R. My Very Own Medicine: What Must I Know? Information Policy for Pharmacogenetics. Cambridge: Wellcome Trust; 2003;
  12. The Royal Society . Pharmacogenetics Dialogue—Findings from Public Workshops on Personalised Medicines Held by the Royal Society's Science in Society Programme. London: Royal Society; 2005;
  13. The Royal Society . Personalised Medicines: Hopes and Realities. London: Royal Society; 2005;
  14. Medicare Australia . Available at: http://www.medicareaustralia.gov.auAccessed 22.03.09
  15. Pharmaceutical Benefits Scheme . Available at: http://www.pbs.gov.au/html/homeAccessed 22.07.08
  16. Krueger RA, Casey MA. Focus Groups: A Practical Guide for Applied Research. 3rd ed.. Sage Publications; 2001;
  17. Pope C, Mays N. Qualitative Research in Health Care. 2nd ed.. Malden, MA: Blackwell Publications; 2006;
  18. Berg BL. Qualitative Research Methods for the Social Sciences. Allyn & Bacon; 1998;
  19. Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data. BMJ. 2000;320(7227):114–116
  20. Chakravorti B. The Slow Pace of Fast Change: Bringing Innovations to Market in a Connected World. Boston: Harvard Business School Press; 2003;
  21. Jallinoja P, Hakonen A, Aro AR, et al. Attitudes towards genetic testing: analysis of contradictions. Soc Sci Med. 1998;46(10):1367–1374
  22. Shah J. Criteria influencing the clinical uptake of pharmacogenomic strategies. BMJ. 2004;328(7454):1482–1486
  23. Moldrup C, Morgall JM, Almarsdóttir AB. Citizen involvement in future drug R&D; a Danish Delphi study. Foresight. 2000;2(5):497–506

PII: S1551-7411(09)00104-1

doi: 10.1016/j.sapharm.2009.08.002

Research in Social and Administrative Pharmacy
Volume 6, Issue 3 , Pages 221-231 , September 2010